NET · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.17B | $1.67B | $1.30B | $975.24M | $656.43M | $431.06M | $287.02M | $192.67M |
| Cost of Revenue | $552.52M | $378.70M | $307.00M | $232.61M | $147.13M | $101.06M | $63.42M | $43.54M |
| Gross Profit | $1.62B | $1.29B | $989.74M | $742.63M | $509.29M | $330.00M | $223.60M | $149.14M |
| Research & Development | $512.49M | $421.37M | $358.14M | $298.30M | $189.41M | $127.14M | $90.67M | $54.46M |
| Selling, General & Administrative | $389.31M | $278.52M | $217.97M | $179.77M | $119.50M | $91.75M | $81.58M | $85.18M |
| Operating Expenses | $1.82B | $1.45B | $1.18B | $943.83M | $636.98M | $436.77M | $331.55M | $234.04M |
| Operating Income | -$207.21M | -$154.76M | -$185.49M | -$201.20M | -$127.68M | -$106.77M | -$107.95M | -$84.90M |
| Interest Expense | — | — | $5.87M | $4.98M | $49.23M | $24.96M | $1.11M | $992.00K |
| Other Income / (Expense) | $114.50M | $83.89M | $7.62M | $10.47M | -$120.29M | -$18.20M | $3.23M | -$1.19M |
| Income Before Taxes | -$92.71M | -$70.87M | -$177.86M | -$190.73M | -$247.98M | -$124.97M | -$104.71M | -$86.09M |
| Provision for Income Taxes | $9.56M | $7.93M | $6.09M | $2.65M | $12.33M | -$5.60M | $1.11M | $1.08M |
| Net Income | -$102.27M | -$78.80M | -$183.95M | -$193.38M | -$260.31M | -$119.37M | -$105.83M | -$87.16M |
| Basic EPS | -$0.29 | -$0.23 | -$0.55 | -$0.59 | -$0.83 | -$0.40 | -$0.72 | — |
| Diluted EPS | -$0.29 | -$0.23 | -$0.55 | -$0.59 | -$0.83 | -$0.40 | -$0.72 | — |
| Basic Shares Outstanding | 348.42M | 341.41M | 333.66M | 326.33M | 312.32M | 299.77M | 146.31M | — |
| Diluted Shares Outstanding | 348.42M | 341.41M | 333.66M | 326.33M | 312.32M | 299.77M | 146.31M | — |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $0.03 | -$0.06 | $0.11 | 12 | ↑0 ↓0 |
| Dec 2027 | $0.29 | -$0.10 | $0.67 | 11 | ↑0 ↓0 |
| Dec 2028 | $0.49 | -$0.08 | $1.06 | 2 | ↑0 ↓0 |